• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Product Image

Athlete's Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019

  • Published: February 2012
  • 59 pages
  • GlobalData

Athlete’s Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019

Summary

GlobalData, the industry analysis specialist, has released its new report, “Athlete’s Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019”. The report is an essential source of information and analysis on the global Athlete's Foot Therapeutics market. The report identifies the key trends shaping and driving the global Athlete's Foot Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Athlete's Foot Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the key drivers and challenges of the Athlete's Foot Therapeutics market. Its scope includes -
- Annualized seven key markets (US, France, Germany, READ MORE >

1
1

1.1 List of Tables
1.2 List of Figures
2 Athlete’s Foot Therapeutics - Introduction
2.1 Disease Overview
2.2 Epidemiology
2.3 Etiology
2.4 Pathophysiology
2.5 Signs and Symptoms
2.6 Diagnosis
2.7 Treatment and Management Options
2.8 GlobalData Pipeline Report Guidance
3 Athlete’s Foot Therapeutics - Market Characterization
3.1 Athlete’s Foot Therapeutics Market Size (2006-2011) - Global
3.2 Athlete’s Foot Therapeutics Market Forecast (2011-2019) - Global
3.3 Athlete’s Foot Therapeutics Market Size (2006-2011) - The US
3.4 Athlete’s Foot Therapeutics Market Forecast (2011-2019) - The US
3.5 Athlete’s Foot Therapeutics Market Size (2006-2011) - France
3.6 Athlete’s Foot Therapeutics Market Forecast (2011-2019) - France
3.7 Athlete’s Foot Therapeutics Market Size (2006-2011) - Germany
3.8 Athlete’s Foot Therapeutics Market Forecast (2011-2019) - Germany
3.9 Athlete’s Foot Therapeutics Market Size (2006-2011) - Italy
3.10 Athlete’s Foot Therapeutics Market Forecast (2011-2019) - Italy
3.11 Athlete’s foot Therapeutics Market Size (2006-2011) - Spain
3.12 Athlete’s Foot Therapeutics Market Forecast (2011-2019) - Spain
3.13 Athlete’s Foot Therapeutics Market Size (2006-2011) - The UK
3.14 Athlete’s Foot Therapeutics Market Forecast (2011-2019) - The UK
3.15 Athlete’s Foot Therapeutics Market Size (2006-2011) - Japan
3.16 Athlete’s Foot Therapeutics Market Forecast (2011-2019) - Japan
3.17 Drivers and Barriers for the Athlete’s Foot Therapeutics Market
3.17.1 Drivers for the Athlete’s Foot Therapeutics Market
3.17.2 Barriers for the Athlete’s Foot Therapeutics Market
3.18 Opportunity and Unmet Need Analysis
3.19 Key Takeaway
4 Athlete’s Foot Therapeutics - Competitive Assessment
4.1 Overview
4.2 Strategic Competitor Assessment
4.3 Product Profiles for the Major Marketed Product Classes in the Athlete’s Foot Therapeutics Market
4.4 Key Takeaway
5 Athlete’s Foot Therapeutics - Pipeline Assessment
5.1 Overview
5.2 Strategic Pipeline Assessment
5.3 Athlete’s Foot Therapeutics Pipeline - Pipeline by Phases of Development
5.3.1 Athlete’s Foot Therapeutics - Phase III Pipeline
5.3.2 Athlete’s Foot Therapeutics - Phase II Pipeline
5.3.3 Athlete’s Foot Therapeutics - Phase I Pipeline
5.3.4 Athlete’s Foot Therapeutics - Pre-Clinical Pipeline
5.3.5 Technology Trends Analytic Framework
5.4 Athlete’s Foot Therapeutics Market - Clinical Pipeline by Mechanism of Action
5.5 Athlete’s Foot Therapeutics - Promising Drugs Under Clinical Development
5.6 Molecule Profiles for Promising Drugs in Clinical Development
5.6.1 Nitric Oxide
5.7 Key Takeaway
6 Athlete’s Foot Therapeutics - Clinical Trials Mapping
6.1 Clinical Trials by Region/Country (The US, EU5 and Japan)
6.2 Clinical Trials by Phase
6.3 Clinical Trials by Trial Status
6.4 Prominent Sponsors
6.5 Clinical Trials by Overall Sponsors
6.6 Top Companies Participating in Athlete’s Foot Therapeutics Clinical Trials
7 Athlete’s Foot Therapeutics - Strategic Assessment
7.1 Key Events Impacting the Future Market
7.2 Athlete’s Foot Therapeutics: Implications for Future Market Competition
8 Athlete’s Foot Therapeutics - Future Companies
8.1 Introduction
8.2 Company Profiles
8.2.1 Quinnova Pharmaceuticals, Inc.
8.2.2 Nitric Biotherapeutics, Inc.
8.2.3 Anacor Pharmaceuticals, Inc.
8.2.4 Other Companies in Market
9 Athlete’s Foot Therapeutics - Licensing and Partnership Deals
10 Athlete’s Foot Therapeutics - Appendix
10.1 Market Definitions
10.2 Abbreviations
10.3 Methodology
10.3.1 Coverage
10.3.2 Secondary Research
10.3.3 Forecasting
10.3.4 Primary Research
10.3.5 Expert Panel Validation
10.4 Contact Us
10.5 Disclaimer
10.6 Bibliography

1.1 List of Tables
Table 1: Prevalence of Athlete’s Foot in the US, EU5 and Japan
Table 2: Athlete’s Foot Therapeutics Market, Global, Revenue ($m), 2006-2011
Table 3: Athlete’s Foot Therapeutics Market, Global, Forecast ($m), 2011-2019
Table 4: Athlete’s Foot Therapeutics Market, The US, Revenue ($m), 2006-2011
Table 5: Athlete’s Foot Therapeutics Market, The US, Forecast ($m), 2011-2019
Table 6: Athlete’s Foot Therapeutics Market, France, Revenue ($m), 2006-2011
Table 7: Athlete’s Foot Therapeutics Market, France, Forecast ($m), 2011-2019
Table 8: Athlete’s Foot Therapeutics Market, Germany, Revenue ($m), 2006-2011
Table 9: Athlete’s Foot Therapeutics Market, Germany, Forecast ($m), 2011-2019
Table 10: Athlete’s Foot Therapeutics Market, Italy, Revenue ($m), 2006-2011
Table 11: Athlete’s Foot Therapeutics Market, Italy, Forecast ($m), 2011-2019
Table 12: Athlete’s Foot Therapeutics Market, Spain, Revenue ($m), 2006-2011
Table 13: Athlete’s Foot Therapeutics Market, Spain, Forecast ($m), 2011-2019
Table 14: Athlete’s Foot Therapeutics Market, The UK, Revenue ($m), 2006-2011
Table 15: Athlete’s Foot Therapeutics Market, The UK, Forecast ($m), 2011-2019
Table 16: Athlete’s Foot Therapeutics Market, Japan, Revenue ($m), 2006-2011
Table 17: Athlete’s Foot Therapeutics Market, Japan, Forecast ($m), 2011-2019
Table 18: Athlete’s Foot Therapeutics - Phase II Pipeline, as of November,2011
Table 19: Athlete’s Foot Therapeutics - Phase II Pipeline, 2011
Table 20: Athlete’s Foot Therapeutics - Phase I Pipeline, 2011
Table 21: Athlete’s Foot Therapeutics - Pre-Clinical Pipeline, 2011
Table 22: Athlete’s Foot Therapeutics -Promising Drugs Under Clinical Development, 2011
Table 23: Athlete’s Foot Therapeutics Market - Clinical Trials by Region/Country, 2011
Table 24: Athlete’s Foot Therapeutics - Clinical Trials by Phase, 2011
Table 25: Athlete’s Foot Therapeutics - Clinical Trials by Status, 2011
Table 26: Athlete’s Foot Therapeutics -Prominent Sponsors, 2011
Table 27: Athlete’s Foot Therapeutics - Overall Sponsors, 2011
Table 28: Athlete’s Foot Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011
Table 29: Quinnova Pharmaceuticals, Inc. Infectious Disease Pipeline, 2011
Table 30: Nitric Biotherapeutics, Inc. - Infectious Disease Pipeline Products, 2011
Table 31: Anacor Pharmaceuticals - Infectious Disease Pipeline, 2011
Table 32: Athlete’s Foot Therapeutics Market - Future Companies
Table 33: Athlete’s Foot Therapeutics, Global, Deals

1.2 List of Figures
Figure 1: Athlete’s Foot
Figure 2: Athlete’s Foot Therapeutics Market, Global, Revenue ($m), 2006-2011
Figure 3: Athlete’s Foot Therapeutics Market, Global, Forecast ($m), 2011-2019
Figure 4: Athlete’s Foot Therapeutics Market, The US, Revenue ($m), 2006-2011
Figure 5: Athlete’s Foot Therapeutics Market, The US, Forecast ($m), 2011-2019
Figure 6: Athlete’s Foot Therapeutics Market, France, Revenue ($m), 2006-2011
Figure 7: Athlete’s Foot Therapeutics Market, France, Forecast ($m), 2011-2019
Figure 8: Athlete’s Foot Therapeutics Market, Germany, Revenue ($m), 2006-2011
Figure 9: Athlete’s Foot Therapeutics Market, Germany, Forecast ($m), 2011-2019
Figure 10: Athlete’s Foot Therapeutics Market, Italy, Revenue ($m), 2006-2011
Figure 11: Athlete’s Foot Therapeutics Market, Italy, Forecast ($m), 2011-2019
Figure 12: Athlete’s Foot Therapeutics Market, Spain, Revenue ($m), 2006-2011
Figure 13: Athlete’s Foot Therapeutics Market, Spain, Forecast ($m), 2011-2019
Figure 14: Athlete’s Foot Therapeutics Market, The UK, Revenue ($m), 2006-2011
Figure 15: Athlete’s Foot Therapeutics Market, The UK, Forecast ($m), 2011-2019
Figure 16: Athlete’s Foot Therapeutics Market, Japan, Revenue ($m), 2006-2011
Figure 17: Athlete’s Foot Therapeutics Market, Japan, Forecast ($m), 2011-2019
Figure 18: Opportunity and Unmet Need in the Athlete’s Foot Therapeutics Market, 2011
Figure 19: Athlete’s Foot Therapeutics - Strategic Competitor Assessment, 2011
Figure 20: Athlete’s Foot Therapeutics - Pipeline by Phase of Development, 2011
Figure 21: Athlete’s Foot Therapeutics - Technology Trends Analytics Framework, 2011
Figure 22: Athlete’s Foot Therapeutics - Technology Trends Analytics Framework - Description, 2011
Figure 23: Athlete’s Foot Therapeutics - Pipeline by Mechanism of Action, 2011
Figure 24: Athlete’s Foot Therapeutics - Clinical Trials by Country, 2011
Figure 25: Athlete’s Foot Therapeutics - Clinical Trials by Phase, 2011
Figure 26: Athlete’s Foot Therapeutics - Clinical Trials by Status, 2011
Figure 27: Athlete’s Foot Therapeutics - Prominent Sponsors, 2011
Figure 28: Athlete’s Foot Therapeutics - Overall Sponsors, 2011
Figure 29: Athlete’s Foot Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011
Figure 30: Athlete’s Foot Therapeutics Market - Drivers and Barriers, 2011
Figure 31: Implications for Future Market Competition in the Athlete’s Foot Market, 2011
Figure 32: Athlete’s Foot Therapeutics Market - Pipeline by Company, 2011
Figure 33: GlobalData Market Forecasting Model

Niche Products will Finish First in Race to Enter Athlete’s Foot Therapeutics Market

Pharmaceuticals companies that have previously shied away from developing treatments for athlete’s foot due to market competitiveness should instead look to niche areas of the disease for commercial opportunity, a new study by business intelligence provider GlobalData has found.

The new report* indicates that, although drug developers may have refrained from entering the competitive athlete’s foot therapeutics market due to the number of treatments already available, an unmet need still exists for cases of resistant athlete’s foot infections. These cases require first-in-class (FIC) anti-fungal drugs and cannot be treated with the available therapies.

The current athlete’s foot therapeutics market is highly competitive, with more than 10 marketed products. The market is dominated by generics classes such as azoles, allylamines and benzylamines, which offer good safety and tolerability profiles, thereby creating strong competition among these products. This increases the difficulty for new entrants by offering only a small window of opportunity to capture market share.

Adding to this difficulty is slow market growth, which could be attributed to the reluctance of athlete’s foot patients to visit doctors for treatment due to the perception that the disease is not a serious infection and the ability to treat the disease with over-the-counter (OTC) drugs in the initial stages.

However, GlobalData has found that the product pipeline for athlete’s foot is weak and, as there are no FIC molecules in the late stage of development, companies have an opportunity to capitalize on this gap in the market. In Phase III, there are three product extensions, which, upon their launch, are not expected to have an impact on the market. There are also FIC molecules in Phase II with novel mechanisms of action, but they will not enter the market until the next decade.

GlobalData’s analysis shows that the global athlete’s foot therapeutics market stood at a value of US$490.0 million in 2006 and grew at a compound annual growth rate (CAGR) of 3.4% to reach US$580.5 million in 2011. Despite factors that may contribute to slow market growth over the next eight years, GlobalData forecasts that the global athlete’s foot therapeutics market will continue to demonstrate a similar CAGR of 3.0% to reach a value of US$735.4 million by 2019.

Athlete’s Foot Therapeutics - Pipeline Assessment and Market Forecasts to 2019

The report is an essential source of information and analysis on the global athlete's foot therapeutics market. The report identifies the key trends shaping and driving the market, while analysis into the prevalent competitive landscape distinguishes the emerging players expected to significantly alter the market positioning of the current leaders. Most importantly, the report provides valuable insights into the pipeline products expected to appear within the global athlete's foot therapeutics sector within the next eight years.

Quinnova Pharmaceuticals, Inc.
Nitric Biotherapeutics, Inc.
Anacor Pharmaceuticals, Inc.

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos